Peritoneal Cancer Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Peritoneal Cancer Market is segmented By Drug Type (Late-stage Products, Mid-stage Products, Early-stage Products), By Route of Administration (Oral, ....
Peritoneal Cancer Market Size
Market Size in USD
CAGR17.9%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 17.9% |
| Market Concentration | High |
| Major Players | AB Science, Zentalis Pharmaceuticals, ImmunoGen, UT Southwestern Medical Center, Avastin |
please let us know !
Peritoneal Cancer Market Analysis
The Global Peritoneal Cancer Market is estimated to be valued at USD 5.9 Bn in 2024 and is expected to reach USD 15.9 Bn by 2031, growing at a compound annual growth rate (CAGR) of 17.9% from 2024 to 2031.
The market is expected to witness positive growth over the forecast period. Increasing incidence of peritoneal carcinomatosis owing to the rising prevalence of cancers such as ovarian and gastric cancer is expected to drive the market. In addition, growing awareness regarding diagnosis and treatment options for peritoneal carcinomatosis is also anticipated to boost the demand. Further, ongoing clinical trials evaluating the efficacy of several systemic therapies for peritoneal carcinomatosis will contribute to market growth. However, high costs associated with diagnosis and treatment procedures may hamper market growth to some extent. Overall, growth in healthcare expenditure and demand for advanced line of treatment for peritoneal cancer worldwide will continue to support the market expansion over the next few years.